Neurocrine Biosciences Inc (NBIX) support and resistance · P/E 45, rev $1.77B
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
This page maps Neurocrine Biosciences Inc (NBIX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new NBIX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the NBIX quote page for the session range and the stock page for the full model.
Not investment advice.